{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:57:54Z","timestamp":1740128274705,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007366","name":"Fondazione Italiana Sclerosi Multipla","doi-asserted-by":"publisher","award":["FISM2016_R_12","FISM2016_R_16"],"award-info":[{"award-number":["FISM2016_R_12","FISM2016_R_16"]}],"id":[{"id":"10.13039\/100007366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13365-019-00793-4","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T16:07:48Z","timestamp":1567094868000},"page":"133-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Early reduction of the splicing factor2\/alternative splicing factor: a cellular inhibitor of the JC polyomavirus in natalizumab-treated MS patients long before developing progressive multifocal leukoencephalopathy"],"prefix":"10.1007","volume":"26","author":[{"given":"Claudia","family":"Piu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Ibba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruggero","family":"Capra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Uleri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Serra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Imberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5815-5310","authenticated-orcid":false,"given":"Antonina","family":"Dolei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"key":"793_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1515\/hsz-2016-0345","volume":"398","author":"B Assetta","year":"2017","unstructured":"Assetta B, Atwood WJ (2017) The biology of JC polyomavirus. Biol Chem 398:839\u2013855. \nhttps:\/\/doi.org\/10.1515\/hsz-2016-0345","journal-title":"Biol Chem"},{"key":"793_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMe058122","volume":"353","author":"JR Berger","year":"2005","unstructured":"Berger JR, Koralnik IJ (2005) Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. N Engl J Med 353:414\u2013416. \nhttps:\/\/doi.org\/10.1056\/NEJMe058122","journal-title":"N Engl J Med"},{"issue":"6","key":"793_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1002\/ana.24148","volume":"75","author":"Spyridon Chalkias","year":"2014","unstructured":"Chalkias S, Dang X, Bord E, Stein MC, Kinkel RP, Sloane JA, Donnelly M, Ionete C, Houtchens MK, Buckle GJ, Batson S, Koralnik IJ (2014) JC virus reactivation during prolonged Natalizumab monotherapy for multiple sclerosis. Ann Neurol 75:925\u2013934. \nhttps:\/\/doi.org\/10.1002\/ana.24148","journal-title":"Annals of Neurology"},{"key":"793_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12985-015-0426-x","volume":"12","author":"M Craigie","year":"2015","unstructured":"Craigie M, Regan P, Otalora YL, Sariyer IK (2015) Molecular interplay between T-antigen and splicing factor, arginine\/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells. Virol J 12:196. \nhttps:\/\/doi.org\/10.1186\/s12985-015-0426-x","journal-title":"Virol J"},{"issue":"8","key":"793_CR5","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1177\/1352458519832259","volume":"25","author":"Simonetta Gerevini","year":"2019","unstructured":"Gerevini S, Capra R, Bertoli D, Sottini A, Imberti L (2019) Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy. Mult Scler 25:1196-1201. \nhttps:\/\/doi.org\/10.1177\/1352458519832259","journal-title":"Multiple Sclerosis Journal"},{"key":"793_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jcv.2013.02.002","volume":"57","author":"P Lee","year":"2013","unstructured":"Lee P, Plavina T, Castro A, Berman M, Jaiswal D, Rivas S, Schlain B, Subramanyam M (2013) A second-generation ELISA (STRATIFY JCV\u2122 DxSelect\u2122) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. J Clin Virol 57:141\u2013146. \nhttps:\/\/doi.org\/10.1016\/j.jcv.2013.02.002","journal-title":"J Clin Virol"},{"key":"793_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jneuroim.2007.11.007","volume":"194","author":"RLP Lindberg","year":"2008","unstructured":"Lindberg RLP, Achtnichts L, Hoffman F, Kuhle J, Kappos L (2008) Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. J Neuroimmunol 194:153\u2013164. \nhttps:\/\/doi.org\/10.1016\/j.jneuroim.2007.11.007","journal-title":"J Neuroimmunol"},{"key":"793_CR8","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fimmu.2018.00138","volume":"9","author":"EA Mill","year":"2018","unstructured":"Mill EA, Mao-Draayer Y (2018) Understanding progressive multifocal leukoencephalopathy risk in multiple sclerosis patients treated with immunomodulatory therapies: a bird\u2019s eye view. Front Immunol 9:138. \nhttps:\/\/doi.org\/10.3389\/fimmu.2018.00138","journal-title":"Front Immunol"},{"key":"793_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/jnnp-2018-319208","volume":"90","author":"C Scarpazza","year":"2019","unstructured":"Scarpazza C, Signori A, Prosperini L, Sormani MP, Cosottini M, Capra R, Gerevini S, Italian PML Group (2019) Early diagnosis of progressive multifocal leucoencephalopathy: longitudinal lesion evolution. J Neurol Neurosurg Psychiatry 90:261\u2013267. \nhttps:\/\/doi.org\/10.1136\/jnnp-2018-319208","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"793_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41582-018-0082-z","volume":"15","author":"M Tintore","year":"2019","unstructured":"Tintore M, Vidal-Jordana A, Sastre-Garriga J (2019) Treatment of multiple sclerosis - success from bench to bedside. Nat Rev Neurol 15:53\u201358. \nhttps:\/\/doi.org\/10.1038\/s41582-018-0082-z","journal-title":"Nat Rev Neurol"},{"key":"793_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/1743-422X-10-147","volume":"10","author":"E Uleri","year":"2013","unstructured":"Uleri E, Regan P, Dolei A, Sariyer IK (2013) SF2\/ASF binding region within JC virus NCCR limits early gene transcription in glial cells. Virol J 10:147. \nhttps:\/\/doi.org\/10.1186\/1743-422X-10-147","journal-title":"Virol J"},{"key":"793_CR12","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s13365-016-0492-x","volume":"23","author":"E Uleri","year":"2017","unstructured":"Uleri E, Ibba G, Piu C, Caocci M, Leoni S, Arru G, Serra C, Sechi G, Dolei A (2017) JC polyomavirus expression and bell-shaped regulation of its SF2\/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab. J Neurovirol 23:226\u2013238. \nhttps:\/\/doi.org\/10.1007\/s13365-016-0492-x","journal-title":"J Neurovirol"},{"key":"793_CR13","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.3892\/mmr.2015.3851","volume":"12","author":"Y Zhao","year":"2015","unstructured":"Zhao Y, Zhu T, Zhang X, Wang Q, Zhang J, Ji W, Ma Y (2015) Splicing factor 2\/alternative splicing factor contributes to extracellular signal regulated kinase activation in hepatocellular carcinoma cells. Mol Med Rep 12:3890\u20133894. \nhttps:\/\/doi.org\/10.3892\/mmr.2015.3851","journal-title":"Mol Med Rep"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00793-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-019-00793-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-019-00793-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T23:52:18Z","timestamp":1598572338000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-019-00793-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1007\/s13365-019-00793-4","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"type":"print","value":"1355-0284"},{"type":"electronic","value":"1538-2443"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Brescia Ethical Committee Board (protocols 2713 of 05\/24\/2017 and NP0 of 07\/18\/2018).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}